Risk Factors of Unfavourable TB Treatment Outcomes in Hulu Langat, Selangor
Main Article Content
Abstract
Introduction: Over the last decade, tuberculosis (TB) has remained the main cause of death from communicable diseases in Malaysia. This study was aimed to determine the risk factors of unfavourable treatment outcomes (UTO) among new TB cases in Hulu Langat. Methods: A cohort study was prospectively conducted among the new TB cases registered in the government health clinics of Hulu Langat district. The event was defined as any one of the UTO (default, transferred out, treatment failure and death) whichever came first. This data was analysed using SPSS version 25.0. Survival pattern was assessed by Kaplan-Meier plots and Log rank test. Hazard ratios of unfavourable TB treatment outcomes among the new TB cases at 95% confidence interval and level of significance set at 0.05 were calculated using Cox proportional hazard model. Results: Of the 321 patients analysed, 80.4% (n=258) had favourable treatment outcomes and 19.6% (n=63) had UTO with 10.9% (n=35) transferred out, 6.9% (n=22) defaulted and 1.9% (n=6) died. There was no treatment failure. The mean survival time was 5.2 (SD=0.09) months. The risk factors of hazard probability of UTO were male, ethnicity type Others, positive human immunodeficiency virus (HIV) status and not done sputum at 2 months of treatment. Conclusion: Transferred out and default formed the bulk of the UTO in Hulu Langat. New interventions to improve the existing TB prevention and control program should be planned in the first three months of treatment.
Downloads
Article Details
References
World Health Organization (WHO). Global tuberculosis report 2020. Geneva, Switzerland: World Health Organization; 2020a. p. xiii-xiv. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
World Health Organization (WHO). TB Profile: Malaysia. Geneva, Switzerland: World Health Organization; 2020b. Retrieved from https://worldhealthorg.shinyapps.io/tb_profiles/
World Health Organization (WHO). Achieving the health-related Millennium Development Goals in the Western Pacific Region 2016: Transitioning to the Sustainable Development Goals. Geneva, Switzerland: World Health Organization; 2016.
Manissero D, Hollo V, Huitric E, Kodmon C, Amato-Gauci A. Analysis of tuberculosis treatment outcomes in the European Union and European Economic Area: efforts needed towards optimal case management and control. Euro Surveill. 2010;15(11)
Ministry of Health Malaysia. Management of Tuberculosis - Clinical Practice Guidelines (3rd Edition). Putrajaya, Malaysia: Malaysia Health Technology Assessment Section (MaHTAS), Ministry of Health, Malaysia; 2012.p 81-82.
Ministry of Health Malaysia (2019). Buletin Sektor Tibi & Kusta Bahagian Kawalan Penyakit Kementerian Malaysia. Bil.1/2019. Published 23 September 2019.
Liew SM, Khoo EM, Ho BK, Lee YK, Mimi O, Fazlina MY, et al. Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry. Int J Tuberc Lung Dis. 2015;19(7):764–71.
Ministry of Health Malaysia. Health Indicators 2010: Indicators for Monitoring and Evaluation of Strategy Health for all. Disease Control Division. Ministry of Health Malaysia. 2010. p 68.
Ministry of Health Malaysia. Health Indicators 2016: Indicators for Monitoring and Evaluation of Strategy Health for all. Disease Control Division. Ministry of Health Malaysia. 2016.p.72.
Ministry of Health Malaysia. Health Indicators 2017: Indicators for Monitoring and Evaluation of Strategy Health for all. Disease Control Division. Ministry of Health Malaysia.2017. p.72.
Ministry of Health Malaysia. Health Indicators 2018: Indicators for Monitoring and Evaluation of Strategy Health for all. Disease Control Division. Ministry of Health Malaysia. 2018.p.72.
Ministry of Health Malaysia. Health Indicators 2019: Indicators for Monitoring and Evaluation of Strategy Health for all. Disease Control Division. Ministry of Health Malaysia. 2019.p.74.
Ministry of Health Malaysia. Health Indicators 2020: Indicators for Monitoring and Evaluation of Strategy Health for all. Disease Control Division. Ministry of Health Malaysia. 2020.p.76
Selangor State Health Department. Laporan Tahunan 2011.p.63, 77-81. 2011
Selangor State Health Department. Laporan Tahunan 2015.p.53, 63-65. 2015
Millet, J. P., Moreno, A., Fina, L., Del Baño, L., Orcau, A., De Olalla, P. G., & Cayla, J. A. (2013). Factors that influence current tuberculosis epidemiology. European Spine Journal, 22(4), 539-548.
Department of Statistics Malaysia (DOSM). Poket Stats Negeri Selangor STI 2020. 2020.
Selangor State Health Department. Health Facts 2015. 2015
World Health Organization. Definitions and reporting framework for tuberculosis–2013 revision. Geneva, Switzerland: World Health Organization; 2013.p.6-7
Department of Statistics, Malaysia. Household Income and Basic Amenities Survey Report by State and Administrative District. Selangor 2019.2020.
Tok PSK, Liew SM, Wong LP, Razali A, Loganathan T, Chinna K, et al. Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study. PLoS One. 2020;15(4): e0231986.
Laws of Malaysia Act 342 Prevention and Control of Infectious Diseases Act 1988. Kuala Lumpur, Malaysia: The Commissioner of Law Revision, Malaysia, 1988.
Dara M, Sulis G, Centis R, d’Ambrosio L, De Vries G, Douglas P, Garcia D, Jansen N, Zuroweste E, Migliori GB. Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences. The International Journal of Tuberculosis and Lung Disease. 2017 Jul 1;21(7):727-36.
Nik N.R. NM, Mohd, NS, Wan, MZ, Sharina, D, Nik, R.NH. Factors associated with unsuccessful treatment outcome of pulmonary tuberculosis in Kota Bharu, Kelantan. Malaysian Journal of Public Health Medicine. 2011;11(1): 6-15.
Ismail I, Bulgiba A. Determinants of unsuccessful tuberculosis treatment outcomes in Malaysian HIV-infected patients. Prev Med. 2013;57 Suppl: S27-30.
Atif M, Sulaiman SAS, Shafie AA, Babar ZU. Duration of treatment in pulmonary tuberculosis: are international guidelines on the management of tuberculosis missing something? Public Health. 2015;129(6):777–82.
Adamu AL, Gadanya MA, Abubakar IS, Jibo AM, Bello MM, Gajida AU, et al. High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infect Dis [Internet]. 2017;17(1). Available from: http://dx.doi.org/10.1186/s12879-017-2249-4
Nájera-Ortiz JC, Sánchez-Pérez HJ, Ochoa-Díaz-López H, Leal-Fernández G, Navarro-Giné A. The poor survival among pulmonary tuberculosis patients in Chiapas, Mexico: The case of Los Altos region. Tuberc Res Treat. 2012; 2012:708423.
Masini EO, Mansour O, Speer CE, Addona V, Hanson CL, Sitienei JK, et al. Using survival analysis to identify risk factors for treatment interruption among new and retreatment tuberculosis patients in Kenya. PLoS One. 2016;11(10): e0164172.
Sulaiman SAS, Khan AH, Muttalif AR, Hassali MA, Ahmad N, Iqubal MS. Impact of diabetes mellitus on treatment outcomes of tuberculosis patients in tertiary care setup. Am J Med Sci. 2013;345(4):321–5.
Jaber AAS, Khan AH, Sulaiman SAS. Evaluating treatment outcomes and durations among cases of smear-positive pulmonary tuberculosis in Yemen: a prospective follow-up study. J Pharm Policy Pract [Internet]. 2017;10(1). Available from: http://dx.doi.org/10.1186/s40545-017-0124-8
Mugomeri E, Bekele BS, Maibvise C, Tarirai C. Trends in diagnostic techniques and factors associated with tuberculosis treatment outcomes in Lesotho, 2010–2015. S Afr J Infect Dis. 2018;33(1):18–23.
Schnaubelt ER, Charles M, Richard M, Fitter DL, Morose W, Cegielski JP. Loss to follow-up among patients receiving anti-tuberculosis treatment, Haiti, 2011-2015. Public Health Action. 2018;8(4):154–61.
Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clin Infect Dis. 2002;34(6):752–9.
Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC public health. 2007 Dec;7(1):1-9.
Noorsuzana Mohd Shariff, Shamsul Azhar Shah, Fadzilah Kamaludin. Impact of ethnic disparities on the treatment outcomes of HIV-negative drug-resistant tuberculosis patients in Kuala Lumpur, Malaysia: A call for a culturally-sensitive community intervention approach. J Glob Antimicrob Resist. 2019;19: 274–9.
Elmi OS, Hasan H, Abdullah S, Jeab MZ, Ba Z, Naing NN. Treatment outcomes of patients with multidrug-resistant tuberculosis (MDR- TB) compared with non-MDR-TB infections in peninsular Malaysia. The Malaysian journal of medical sciences: MJMS. 2016 Jul;23(4):17.
Karo B, Krause G, Hollo V, van der Werf MJ, Castell S, Hamouda O, Haas W. Impact of HIV infection on treatment outcome of tuberculosis in Europe. Aids. 2016 Apr 24;30(7):1089-98.
García-Basteiro AL, Respeito D, Augusto OJ, López-Varela E, Sacoor C, Sequera VG, Casellas A, Bassat Q, Manhiça I, Macete E, Cobelens F. Poor tuberculosis treatment outcomes in Southern Mozambique (2011–2012). BMC infectious diseases. 2016 Dec;16(1):1-9.
Aibana O, Slavuckij A, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB. Patient predictors of poor drug sensitive tuberculosis treatment outcomes in Kyiv Oblast, Ukraine. F1000Research. 2017;6.
Kirenga BJ, Levin J, Ayakaka I, Worodria W, Reilly N, Mumbowa F, Nabanjja H, Nyakoojo G, Fennelly K, Nakubulwa S, Joloba M. Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study. PLoS One. 2014 Mar 7;9(3):e90614.
Ifa AC. Human immunodeficiency virus as a determinant of tuberculosis treatment outcome in tuberculosis patients treated at Arba Minch General Hospital: a five-year retrospective study. HIV & AIDS Review. International Journal of HIV-Related Problems. 2018 Jan 1;17(2):74-80.
Prado TN do, Rajan JV, Miranda AE, Dias EDS, Cosme LB, Possuelo LG, et al. Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis. Braz J Infect Dis. 2017;21(2):162–70.
Dooley KE, Lahlou O, Ghali I, Knudsen J, Elmessaoudi MD, Cherkaoui I, et al. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health. 2011;11(1):140.